July 6, 2023
Webinar
Strafford Publications
As part of the Strafford Publications’ virtual programming, Finnegan attorneys Mark Feldstein, Cora Holt, and Kyu Yun Kim will discuss the Federal Circuit's recent GSK v. Teva decision, post-launch non-Hatch Waxman pharmaceutical litigation, and strategies and tactics regarding claim language and label language. For more information, or to register, please see Strafford’s website.
Federal Circuit IP Blog
July 8, 2026
Federal Circuit IP Blog
June 26, 2026
Federal Circuit IP Blog
Federal Circuit Reinforces Injury-in-Fact Requirement in Appeals from Post-Grant Proceedings
June 10, 2026
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.